GÜNAY, Sibel et al. Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up: Interstitial lung disease following severe COVID-19 pneumonia. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, Fidenza, Italy, v. 40, n. 3, p. e2023029, 2023. DOI: 10.36141/svdld.v40i3.14418. Disponível em: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/14418.. Acesso em: 27 jul. 2024.